n-(2-hydroxypropyl)methacrylamide has been researched along with irinotecan in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hantke, T; Lepenies, B; Seeberger, PH; Thang, SH; Tsanaktsidis, J; Vogel, U; Williams, CC | 1 |
1 other study(ies) available for n-(2-hydroxypropyl)methacrylamide and irinotecan
Article | Year |
---|---|
RAFT-derived polymer-drug conjugates: poly(hydroxypropyl methacrylamide) (HPMA)-7-ethyl-10-hydroxycamptothecin (SN-38) conjugates.
Topics: Acrylamides; Animals; Antineoplastic Agents; Camptothecin; Cell Line; Cell Survival; Humans; Irinotecan; Mice; Polymers; Solubility | 2012 |